Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

APR 24, 2014 - Benzinga

A Must Read - Share

Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary

Biotech giant Gilead Sciences' (NASDAQ: GILD) earnings have cheered the equity markets yet again. Soaring sales of the company's blockbuster drug Sovaldi have catapulted the company's top and bottom line far beyond expectations.  

Tags: Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary,  Amgen Latest News